Notably, heterozygotes for germline P/LP variants in GATA2, ETV6, and RUNX1 (both cohorts), and DDX41 (UKBB only) have significantly increased risk for developing hematological malignancies. This evidence concerns the gene RUNX1 and hematologic disorder.